Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2 Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors

NCT05949632 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.

NCT NCT05949632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05949632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2 Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors
Lead sponsor
Incyte Corporation
Phase
Phase 1/2
Overall status
Terminated
Start date
April 16, 2024
Completion date
June 6, 2025
Enrollment
5 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors